Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
- 1 July 1989
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 86 (13) , 5168-5172
- https://doi.org/10.1073/pnas.86.13.5168
Abstract
The role of the hepatitis B virus (HBV) X gene during virus infection has not been defined. We previously showed that expression of the HBV X gene in the human hepatocellular carcinoma cell line HepG2 trans-activates chloramphenicol acetyltransferase gene expression under control of the human immunodeficiency virus 1 (HIV-1) long terminal repeat and we have now identified a specific sequence in the HIV-1 long terminal repeat that is responsive to the HBV X gene. Plasmid constructs with the chloramphenicol acetyltransferase gene regulated by an isolated and twice-repeated 12-base-pair HIV-1 enhancer sequence homologous to the nucleotide sequence that binds the nuclear transcription factor NF-kB (the HIV-1 kB-like sequence) were trans-activated by the HBV X GENE IN HepG2 cells, indicating that the kB-like enhancer sequence in the HIV-1 long terminal repeat is responsive to the X gene. When eight copies of the HIV-1kB-like sequence were used to regulate .beta.-globin gene expression, transcription of this gene was activated by the HBV X gene in HepG2 cells and no .beta.-globin gene transcription was detected in the absence of the HBV X gene. .beta.-globin gene expression regulated by the activator protein 2 (AP-2) binding sequence was not activated by the HBV X gene. Treatment of HepG2 cells with phorbol ester resulted in modest activation of the HIV-1 kB-like enhancer sequence suggesting that an NF-kB-like factor was induced in these cells as it is in T lymphocytes by phorbol ester; however, phorbol ester did not demonstrably enhance the activation of the HIV-1 enhancer observed with the HBV X gene. These experiments indicate that the HIV-1 kB-like transcriptional enhancer sequence is activated by the HBV X gene and suggest that the HBV X gene might play a role in regulating transcription of a gene under control of a kB-like enhancer during HBV infection. Since such a sequence has not been found in the HBV genome and HBV gene expression appears not to be regulated by the HBV X gene, a cellular gene that plays a role in HBV replication could be the target of the X gene during HBV infection.This publication has 41 references indexed in Scilit:
- Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virusCell, 1988
- Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-IScience, 1987
- Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol estersNature, 1987
- Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNACell, 1986
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986
- Hepatitis B virus DNA Sequences in Lymphoid Cells from Patients with AIDS and AIDS-Related ComplexScience, 1985
- Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virusNature, 1983
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982
- Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donorCell, 1978
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976